Cargando…

216. Step-down Therapy With Oral Fluoroquinolones vs. Oral β-Lactams for Hospitalized Adult Patients with Community-Acquired Pneumonia: A Multi-Hospital Cohort Study

BACKGROUND: Community-acquired pneumonia (CAP) guidelines recommend transition to an oral (PO) β-lactam (BL) regimen or fluoroquinolone (FQ) when patients are clinically stable. Due to collateral damage associated with FQs, stewardship efforts often focus on reducing initial FQ use for CAP therapy....

Descripción completa

Detalles Bibliográficos
Autores principales:	Petty, Lindsay, Patel, Twisha S, Conlon, Anna, Nielsen, Daniel, Vaughn, Valerie, Kaye, Keith, Malani, Anurag, Osterholzer, Danielle, Thyagarajan, Rama, Flanders, Scott, Gandhi, Tejal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254695/ http://dx.doi.org/10.1093/ofid/ofy210.228

Ejemplares similares

1876. Patient- and Hospital-Level Factors and Outcomes Associated With Treatment of Asymptomatic Bacteriuria in Hospitalized Patients: A Multi-Hospital Cohort Study
por: Petty, Lindsay, et al.
Publicado: (2018)

869. Evaluation of Broad-Spectrum Antibiotic De-Escalation in Patients with Health-Care Associated Pneumonia (HCAP) and No Microbiological Diagnosis
por: Patel, Twisha S, et al.
Publicado: (2018)

1106. Assessment of Fluoroquinolone Appropriateness for Hospitalized Patients with Asymptomatic Bacteriuria and Cystitis: A Multi-Hospital Cohort Study
por: Gandhi, Tejal N, et al.
Publicado: (2019)

The Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study
por: Vaughn, Valerie M, et al.
Publicado: (2019)

1870. Excess Antibiotic Duration in Patients Hospitalized for Pneumonia: A Multi-Hospital Cohort Study
por: Vaughn, Valerie, et al.
Publicado: (2018)

1083. Risk Factors Associated with Treatment of Asymptomatic Bacteriuria in the Emergency Department: A Multi-Hospital Cohort Study
por: Petty, Lindsay A, et al.
Publicado: (2019)

2893. The Michigan Hospital Medicine Safety Consortium: Improving Patient Care by Reducing Excessive Antibiotic Use in Patients Hospitalized with Community-Acquired Pneumonia
por: Gandhi, Tejal N, et al.
Publicado: (2019)

Three-day antibiotic duration in patients with pneumonia: A sixty-eight–hospital cohort
por: Vaughn, Valerie, et al.
Publicado: (2023)

A Deeper Dive Into Antibiotic Stewardship Needs: A Multihospital Survey
por: Vaughn, Valerie M, et al.
Publicado: (2020)

Assessment of Testing and Treatment of Asymptomatic Bacteriuria Initiated in the Emergency Department
por: Petty, Lindsay A, et al.
Publicado: (2020)

2890. Antibiotic Overuse at Discharge in Hospitalized Patients with Bacteriuria or Treated for Pneumonia: A Multi-Hospital Cohort Study
por: Vaughn, Valerie M, et al.
Publicado: (2019)

Identifying the relationship between hospital rurality and antibiotic overuse
por: Hardin, Hannah, et al.
Publicado: (2023)

Risk Factors and outcomes associated with inappropriate empiric broad-spectrum antibiotic use in hospitalized patients with community-acquired pneumonia
por: Gandhi, Tejal, et al.
Publicado: (2023)

Prevalence of and risk factors for bacteremic UTIs in hospitalized adults without definitive signs or symptoms of UTI
por: Advani, Sonali, et al.
Publicado: (2023)

1592. SHEA Featured Oral Abstract: Reducing Unnecessary Antibiotic Treatment for Asymptomatic Bacteriuria: A Statewide Collaborative Quality Initiative
por: Vaughn, Valerie, et al.
Publicado: (2022)

A Statewide Collaborative Quality Initiative to Improve Antibiotic Duration and Outcomes in Patients Hospitalized With Uncomplicated Community-Acquired Pneumonia
por: Vaughn, Valerie M, et al.
Publicado: (2021)

74. Empiric Antibiotic Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study
por: Vaughn, Valerie, et al.
Publicado: (2020)

Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study
por: Vaughn, Valerie M, et al.
Publicado: (2020)

Variation in COVID-19 characteristics, treatment and outcomes in Michigan: an observational study in 32 hospitals
por: Chopra, Vineet, et al.
Publicado: (2021)

Antibiotic Overuse After Hospital Discharge: A Multi-hospital Cohort Study
por: Vaughn, Valerie M, et al.
Publicado: (2020)

Association of Infectious Disease Physician Approval of Peripherally Inserted Central Catheter With Appropriateness and Complications
por: Vaughn, Valerie M., et al.
Publicado: (2020)

Antibiotic stewardship strategies and antibiotic overuse after hospital discharge: Analysis of the ROAD Home Framework
por: Vaughn, Valerie, et al.
Publicado: (2022)

Comparison of fidaxomicin to oral vancomycin for the treatment of Clostridioides difficile infection in hospitalized patients
por: Rao, A. Krishna, et al.
Publicado: (2022)

277. Comparison of Oral Beta-Lactams and Fluoroquinolones for Step-Down in Uncomplicated Enterobacterales Blood Stream Infections
por: Ngo, Nichol, et al.
Publicado: (2020)

A Statewide Quality Initiative to Reduce Unnecessary Antibiotic Treatment of Asymptomatic Bacteriuria
por: Vaughn, Valerie M., et al.
Publicado: (2023)

1072. Streamlining to Oral β-Lactam vs. Fluoroquinolone as Definitive Therapy for Enterobacteriaceae Bacteremia
por: Fong, Karen, et al.
Publicado: (2018)

Antibiotic Stewardship Strategies and Their Association With Antibiotic Overuse After Hospital Discharge: An Analysis of the Reducing Overuse of Antibiotics at Discharge (Road) Home Framework( )
por: Vaughn, Valerie M, et al.
Publicado: (2022)

2724. Community-acquired Pneumonia in Immunocompromised Patients: Predictors and Outcomes Associated with Empiric Broad-spectrum Antibiotic Treatment
por: Saravolatz, Louis, et al.
Publicado: (2023)

Oral Fluoroquinolone or Trimethoprim-Sulfamethoxazole vs ß-Lactams as Step-Down Therapy for Enterobacteriaceae Bacteremia: Systematic Review and Meta-analysis
por: Punjabi, Chitra, et al.
Publicado: (2019)

A Multi-Faceted Antimicrobial Stewardship Program (ASP) Intervention Using Clinical Pharmacists Reduces Antibiotic Use and Hospital-Acquired Clostridium difficile Infection (HA-CDI)
por: Boyd, Anthony M, et al.
Publicado: (2017)

165. Comparative Effectiveness of Oral Fluoroquinolones vs. β-Lactams for the Treatment of Patients with Enterobacteriaceae Bloodstream Infections
por: Bjork, Lauren, et al.
Publicado: (2019)

271. Clinical Outcomes Treating Gram-Negative Bacteremia with Oral Beta-Lactams vs. Trimethoprim-Sulfamethoxazole or Fluoroquinolone Step-Down Therapy
por: Sinclair, Emily, et al.
Publicado: (2020)

1822. Clinical Outcomes Associated with Oral Beta-Lactam Therapy versus Oral Fluoroquinolones/TMP-SMX for Uncomplicated Gram-Negative Bacteremia
por: Kaur, Satwinder S, et al.
Publicado: (2022)

The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia
por: Mortensen, Eric M, et al.
Publicado: (2006)

1600. Susceptibility of β-Lactam-Resistant Pseudomonas aeruginosa to Other β-Lactams: Is There Truly a Lack of Cross-Resistance?
por: Patel, Twisha S, et al.
Publicado: (2019)

Outcomes of high-dose oral beta-lactam definitive therapy compared to fluoroquinolone or trimethoprim-sulfamethoxazole oral therapy for bacteremia secondary to a urinary tract infection
por: Geyer, Abigail C., et al.
Publicado: (2023)

Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source
por: Sutton, Jesse D., et al.
Publicado: (2020)

Comparative-Effectiveness of Oral Beta-Lactams and Fluoroquinolones for Stepdown Therapy in Patients with Enterobacterales Bloodstream Infections: A Retrospective Cohort Study
por: Bjork, Lauren, et al.
Publicado: (2023)

Multidrug Resistance Profiles and Resistance Mechanisms to β-Lactams and Fluoroquinolones in Bacterial Isolates from Hospital Wastewater in Bangladesh
por: Manik, Rasel Khan, et al.
Publicado: (2023)

210. Step-down from IV to oral therapy in patients with bacteremia due to Enterobacteriaceae: fluoroquinolones (FQ) vs. ß-lactams (BL) or trimethoprim-sulfamethoxazole (TMP-SMX)
por: Meng, Lina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k61edghqfpthkqhou2rb6re3bn